GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (WBO:GLPG) » Definitions » Cyclically Adjusted Book per Share

Galapagos NV (WBO:GLPG) Cyclically Adjusted Book per Share : €31.92 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Galapagos NV Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Galapagos NV's adjusted book value per share for the three months ended in Dec. 2023 was €42.423. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €31.92 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Galapagos NV's average Cyclically Adjusted Book Growth Rate was 14.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 22.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Galapagos NV was 22.80% per year. The lowest was 22.80% per year. And the median was 22.80% per year.

As of today (2024-05-04), Galapagos NV's current stock price is €26.88. Galapagos NV's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €31.92. Galapagos NV's Cyclically Adjusted PB Ratio of today is 0.84.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Galapagos NV was 11.69. The lowest was 0.84. And the median was 2.18.


Galapagos NV Cyclically Adjusted Book per Share Historical Data

The historical data trend for Galapagos NV's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galapagos NV Cyclically Adjusted Book per Share Chart

Galapagos NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 17.30 21.36 27.90 31.92

Galapagos NV Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.90 28.05 29.44 30.59 31.92

Competitive Comparison of Galapagos NV's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Galapagos NV's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galapagos NV's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galapagos NV's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Galapagos NV's Cyclically Adjusted PB Ratio falls into.



Galapagos NV Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Galapagos NV's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book= Book Value per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=42.423/128.2922*128.2922
=42.423

Current CPI (Dec. 2023) = 128.2922.

Galapagos NV Quarterly Data

Book Value per Share CPI Adj_Book
201312 5.610 99.462 7.236
201406 7.552 99.482 9.739
201409 0.000 99.195 0.000
201412 6.803 99.086 8.808
201503 0.000 99.423 0.000
201506 11.401 100.107 14.611
201509 10.735 100.245 13.738
201512 9.341 100.572 11.916
201603 15.894 101.653 20.059
201606 15.828 102.267 19.856
201609 15.324 102.118 19.252
201612 16.402 102.614 20.506
201703 16.174 103.972 19.957
201706 21.016 103.902 25.949
201709 0.000 104.170 0.000
201712 19.867 104.804 24.319
201803 17.553 105.419 21.362
201806 17.252 106.063 20.868
201809 21.883 106.618 26.332
201812 22.294 107.252 26.668
201903 21.528 107.876 25.602
201906 20.856 107.896 24.798
201909 40.922 107.470 48.851
201912 44.469 108.065 52.793
202003 43.815 108.550 51.784
202006 42.499 108.540 50.233
202009 41.507 108.441 49.105
202012 40.824 108.511 48.266
202103 41.236 109.522 48.303
202106 40.650 110.305 47.279
202109 39.942 111.543 45.940
202112 40.324 114.705 45.101
202203 40.315 118.620 43.602
202206 40.270 120.948 42.715
202209 40.865 124.120 42.239
202212 38.369 126.578 38.889
202303 38.918 126.528 39.461
202306 39.212 125.973 39.934
202309 39.783 127.083 40.162
202312 42.423 128.292 42.423

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Galapagos NV  (WBO:GLPG) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Galapagos NV's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=26.88/31.92
=0.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Galapagos NV was 11.69. The lowest was 0.84. And the median was 2.18.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Galapagos NV Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Galapagos NV's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Galapagos NV (WBO:GLPG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (WBO:GLPG) » Definitions » Cyclically Adjusted Book per Share
Address
Generaal De Wittelaan L11 A3, Mechelen, BEL, 2800
Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.